Semus Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Semus Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-428	Closed	-$210K	–	120
2026 Q1	$210K	Buy	428 +6	+1%	+$3.26K	0.12%	102
2025 Q4	$244K	Buy	+422	New	+$239K	0.13%	92
2025 Q2	–	Sell	-452	Closed	-$225K	–	120
2025 Q1	$225K	Sell	452 -19	-4%	-$10.3K	0.16%	97
2024 Q4	$245K	Buy	471 +18	+4%	+$9.9K	0.16%	94
2024 Q3	$280K	Buy	453 +79	+21%	+$46.8K	0.2%	94
2024 Q2	$207K	Sell	374 -27	-7%	-$15.5K	0.16%	109
2024 Q1	$233K	Sell	401 -76	-16%	-$42.6K	0.2%	111
2023 Q4	$253K	Sell	477 -14	-3%	-$6.78K	0.21%	100
2023 Q3	$249K	Sell	491 -3	-0.6%	-$1.6K	0.23%	93
2023 Q2	$258K	Sell	494 -21	-4%	-$11.3K	0.24%	93
2023 Q1	$297K	Sell	515 -3	-0.6%	-$1.69K	0.32%	79
2022 Q4	$285K	Buy	+518	New	+$274K	0.35%	73

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Semus Wealth Partners's TMO Position: Q2 2026 in Review

Semus Wealth Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 428 shares — an estimated $210K sold.

Semus Wealth Partners first reported a position in TMO in Q4 2022 and held it in 12 quarters. The position peaked at $297K in Q1 2023. 2,621 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Semus Wealth Partners reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Semus Wealth Partners sold 428 Thermo Fisher Scientific shares in Q2 2026, an estimated $210K.
Semus Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 12 quarters.
Semus Wealth Partners's Thermo Fisher Scientific position peaked at $297K in Q1 2023.
2,621 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Semus Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.